SCHEMBL497216

SCHEMBL497216

[c]1nnc(-c2nccnn2)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5553224 0.69
SCHEMBL29522058 0.69
SCHEMBL497217 0.67 NOTUM (0.44)
SCHEMBL967548 0.63 PDPK1 (0.38)
SCHEMBL19435586 0.61 CLK4 (0.38)
SCHEMBL17802320 0.59
SCHEMBL969568 0.58
SCHEMBL7000232 0.58
SCHEMBL11349616 0.58
SCHEMBL21315699 0.58 L3MBTL1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 316 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7855212-B2 Pyridinyl acetonitriles MERCK SERONO SA (CH) 2010-12-21 US claimed
EP-1320526-B1 PHARMACEUTICALLY ACTIVE BENZSULFONAMIDE DERIVATIVES AS INHIBITORS OF PROTEIN JUNKINASES MERCK SERONO SA (CH) 2010-08-18 EP claimed
EP-1399156-A2 ALKYLIDENE PIRAZOLIDINEDIONE DERIVATIVES AND THEIR USE FOR TREATING DIABETES AND OBESITY Applied Research Systems ARS Holding N.V. (AN) 2004-03-24 EP claimed
WO-2002102359-A2 ALKYLIDENE PYRAZOLIDINEDIONE DERIVATIVES AND USE FOR TREATING DIABETES AND OBESITY APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2002-12-27 WO claimed
WO-2024074436-A1 LACTATE ENHANCING COMPOUNDS AND USES THEREOF GLIAPHARM SA (CH) 2024-04-11 WO disclosed
EP-4077308-B1 ANTI-MALARIAL AGENTS UNIV TEXAS (US) 2024-02-14 EP disclosed
US-20230372306-A1 COMPOSITIONS AND METHODS FOR DELAYING THE INCIDENCE OF LABOR XOMA (US) LLC 2023-11-23 US disclosed
US-20230277501-A1 METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION THE JOHNS HOPKINS UNIVERSITY 2023-09-07 US disclosed
EP-4132918-A1 NEW ANTI-MALARIAL AGENTS University Of Kentucky Research Foundation (US) 2023-02-15 EP disclosed
EP-3892332-A1 NEW ANTI-MALARIAL AGENTS University Of Kentucky Research Foundation (US) 2021-10-13 EP disclosed
WO-2021191412-A1 CATHEPSIN SUBSTRATES &amp; CATHEPSIN INHIBITORS AND USES THEREOF ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) 2021-09-30 WO disclosed
EP-3884948-A1 CATHEPSIN INHIBITORS AND USES THEREOF Ecole Polytechnique Fédérale de Lausanne (EPFL) (CH) 2021-09-29 EP disclosed
WO-2001029028-A1 9- (PIPERAZINYLALKYL) CARBAZOLES AS BAX-MODULATORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2001-04-26 WO disclosed
EP-1094063-A1 9-(Piperazinylalkyl)carbazoles as Bax-modulators Applied Research Systems ARS Holding N.V. (AN) 2001-04-25 EP disclosed
WO-2001023379-A1 PHARMACEUTICALLY ACTIVE SULFONYL AMINO ACID DERIVATIVES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2001-04-05 WO disclosed
WO-2001023378-A1 PHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2001-04-05 WO disclosed
WO-2001023382-A1 PHARMACEUTICALLY ACTIVE SULFONYL HYDRAZIDE DERIVATIVES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2001-04-05 WO disclosed
EP-1088822-A1 Pharmaceutically active sulfonyl hydrazide derivatives Applied Research Systems ARS Holding N.V. (AN) 2001-04-04 EP disclosed
EP-1088821-A1 Pharmaceutically active sulfonamide derivatives Applied Research Systems ARS Holding N.V. (AN) 2001-04-04 EP disclosed
EP-1088815-A1 Pharmaceutically active sulfonyl amino acid derivatives Applied Research Systems ARS Holding N.V. (AN) 2001-04-04 EP disclosed